"We did not meet our financial goals in 2024, and that's reflected in our corporate bonus," a company representative told ...
Companies inform investors of possible business risks from Trump's government changes, tucking warnings into extensive "risk ...
CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...
President Trump's government overhaul in annual reports, highlighting risks from tariffs to healthcare reforms.
3don MSN
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.
In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...
Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.
The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to ...
2d
Medpage Today on MSNHealth Execs Showered Trump With Millions; CDC Data Altered; Healthcare BankruptciesValentina Dabos, lead author of the tracker, said in a statement that the consequences of bankruptcies in healthcare "can be ...
CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...
In this article, we will look at the 10 Best Performing Healthcare Stocks So Far in 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results